605033 fundamentals
An in-depth look to SHAANXI MEIBANG PHARMACEUTICAL GROUP operating, investing, and financing activities
605033 free cash flow for Q1 24 is -69.72 M CNY. For 2023, 605033 free cash flow was 137.61 M CNY and operating cash flow was 341.3 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM